ALVO · Alvotech · Metrics
$4.77
+0.02 (+0.42%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$1.69B
Shares
356.82M
Volume · Oct 27
733.47K
Avg daily vol (3M)
1.1M
ALVO metrics
61 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$4.75
Market cap
$1.69B
Price action
20 metricsPrice change (1W)
-7.2%
Price change (30D)
-22.8%
Price change (3M)
+53.2%
Price change (6M)
+34.9%
Price change (YTD)
-7.4%
Price change (1Y)
-41.6%
Trailing year
Price change (5Y)
—
52-week high
$8.13
52-week low
$3.00
Change from 52-week high
-41.6%
Change from 52-week low
+58.3%
Annualized volatility
79.1%
Annualized volatility (3M)
78.6%
Beta
0.8
RSI (14D)
39.5
Price vs SMA 50
-9.9%
Price vs SMA 200
+12.8%
Avg volume (3M)
1.10M
Relative volume
0.7
Average dollar volume
$5.51M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
356.82M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.0%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-12
Last earnings
2026-08-20
Profitability
9 metricsGross margin
60.4%
Operating margin
9.7%
Trailing 12 months
Net margin
4.8%
Gross profit (TTM)
$297.38M
Operating profit (TTM)
$47.54M
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+19.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$491.95M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.4%
Year over year · more shares
Revenue CAGR (3Y)
+91.9%
Revenue CAGR (5Y)
+54.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
1.9%
Debt / equity
—
Current ratio
1.6
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
1.0
Interest coverage
0.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$172.36M
Total assets
$1.59B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
$62.67M
R&D (TTM)
$137.67M
SG&A (TTM)
—
Stock compensation (TTM)
$9.22M
R&D / revenue
28.0%
Stock compensation / revenue
1.9%
Ownership (13F)
9 metrics13F filers
76
13F filer change QoQ
+15
Institutional ownership
13.4%
Conviction holders (share of 13F filers)
2.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+246.4%
Holder tenure
5.4
Price vs estimated holder cost
-26.2%
Ownership (registered funds)
1 metricsIndex-fund ownership
1.0%
Short interest
3 metricsShort interest
1.8%
Latest settlement · 5.7 days to cover
Days to cover
5.7d
Short-squeeze score
49 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—